Fonte: Thyroid. Nome do evento: International Thyroid Congress. Unidade: FM
Assuntos: NEOPLASIAS DA TIREOIDE, CARCINOMA MEDULAR, VETORES, HERPES SIMPLES, ADENOVÍRUS, INTERLEUCINAS, CULTURA DE CÉLULAS, APOPTOSE, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEIDENBERGER, Katia et al. Adenoviral-mediated gene therapy for medullary thyroid carcinoma by combined expression of thyrmidine kinase and human interleukin-12 gene under control of calcitonin promoter. Thyroid. New York: American Thyroid Association. Disponível em: http://online.liebertpub.com/doi/pdfplus/10.1089/thy.2005.15.s-1. Acesso em: 06 out. 2024. , 2005APA
Seidenberger, K., Rubio, I. G. S., Medeiros-Neto, G. E. R. A. L. D. O., Degroot, L. J., & Camargo, R. Y. A. (2005). Adenoviral-mediated gene therapy for medullary thyroid carcinoma by combined expression of thyrmidine kinase and human interleukin-12 gene under control of calcitonin promoter. Thyroid. New York: American Thyroid Association. Recuperado de http://online.liebertpub.com/doi/pdfplus/10.1089/thy.2005.15.s-1NLM
Seidenberger K, Rubio IGS, Medeiros-Neto GERALDO, Degroot LJ, Camargo RYA. Adenoviral-mediated gene therapy for medullary thyroid carcinoma by combined expression of thyrmidine kinase and human interleukin-12 gene under control of calcitonin promoter [Internet]. Thyroid. 2005 ; 15 S-189.[citado 2024 out. 06 ] Available from: http://online.liebertpub.com/doi/pdfplus/10.1089/thy.2005.15.s-1Vancouver
Seidenberger K, Rubio IGS, Medeiros-Neto GERALDO, Degroot LJ, Camargo RYA. Adenoviral-mediated gene therapy for medullary thyroid carcinoma by combined expression of thyrmidine kinase and human interleukin-12 gene under control of calcitonin promoter [Internet]. Thyroid. 2005 ; 15 S-189.[citado 2024 out. 06 ] Available from: http://online.liebertpub.com/doi/pdfplus/10.1089/thy.2005.15.s-1
